Tandem Diabetes Care (TNDM) PT Lowered to $13 at Wells Fargo
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- Wall St futures mixed as Apple falls on margin warning, midterm results awaited
- Apple beats quarterly estimates for profit and revenue
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mailGet Alerts TNDM Hot Sheet
Price: $18.67 --0%
Rating Summary:
19 Buy, 15 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 15 | New: 12
Rating Summary:
19 Buy, 15 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 15 | New: 12
Join SI Premium – FREE
Wells Fargo analyst Lawrence Biegelsen lowered the price target on Tandem Diabetes Care (NASDAQ: TNDM) to $13.00 (from $20.00) while maintaining a Equal Weight rating.
You May Also Be Interested In
- Tandem Diabetes Care Announces Upcoming Conference Presentations
- Hilton Grand Vacations (HGV) PT Lowered to $60 at Mizuho
- Marvell (MRVL) PT Lowered to $285 at Wells Fargo
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
